Live Breaking News & Updates on Oehringers Jardiance

Stay updated with breaking news from Oehringers jardiance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

​​Boehringer's Jardiance now gets CDSCO nod for chronic kidney disease

The Central Drugs Standard Control Organisation of India has approved Jardiance, a 10mg dosage form of empagliflozin, for the treatment of chronic kidney disease (CKD). This approval allows nephrologists and cardiologists to use Jardiance for eligible CKD patients, reducing hospitalizations and addressing unmet medical needs. ....

Gagandeep Singh Bedi , Central Drugs Standard Control Organisation Of India , Boehringer Ingelheim , Central Drugs Standard Control Organisation , Oehringers Jardiance , Chronic Kidney Disease , Chronic Kidney Disease Drug India ,